AVIENCE BIOMEDICALS LTD Hits Upper Circuit for the 2nd Straight Session on NSE, 28 October 2026

AVIENCE BIOMEDICALS LTD has now stopped at the exchange limit in two sessions in a row, and the AVIENCE BIOMEDICALS upper circuit streak on NSE stands at Rs 270.9 on 28 October 2026, a 5% rise from the previous close of Rs 258. The market cap is Rs 141.51 crore.

A 5% rise to the band price leaves nothing further for the band to add, so the price sat at its ceiling with the day high equal to it at the time of writing.

Key Takeaways

• AVIENCE BIOMEDICALS LTD (AVIENCE) hit the upper circuit on NSE at Rs 270.9 on 28 October 2026.
• The session move was +5% against a previous close of Rs 258.
• Market capitalisation stood at Rs 141.51 crore with a PE ratio of 16.17.
• This is the 2nd straight session at the upper circuit, with the run starting on 27 October 2026.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	AVIENCE BIOMEDICALS LTD
Current Price / LTP	Rs 270.9
Day Move	5%
Previous Close	Rs 258
Day Open	Rs 264.4
Day High	Rs 270.9
Day Low	Rs 264.4
Upper Circuit Price	Rs 270.9
Upper Circuit Limit	Rs 270.9
Market Cap	Rs 141.51 crore
Selected Exchange	NSE
PE Ratio	16.17

All figures above are as of 28 October 2026, sourced from Univest market data for the NSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

The session started at Rs 264.4, already above the previous close of Rs 258, and that opening print doubled as the day low. The ascent that followed ended at Rs 270.9, where the day high and the band price coincide.

The change is Rs 12.9, or 5%. A session that never trades beneath its opening level and ends its climb at the limit shows a one-directional path through the range from Rs 264.4 to Rs 270.9.

NSE is the only source for these figures, so the open, the range and the previous close are on a single exchange, with no number mixed in from another venue.

The AVIENCE BIOMEDICALS Upper Circuit Streak So Far

This is session 2 of an unbroken run for AVIENCE BIOMEDICALS LTD. The streak began on 27 October 2026, from a base price of Rs 252. Across the run the stock has moved 7.5% in total.

A repeated upper circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.

This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.

Why AVIENCE BIOMEDICALS LTD Hit Upper Circuit

Demand lifted AVIENCE BIOMEDICALS LTD into its price band, and the upper circuit held the price at Rs 270.9 for a second session. Neither a company statement nor a verified outside trigger was found, so the move can only be read through price action and market sentiment.

No attribution is made to results, a corporate step, healthcare sector news or market talk, because none of them was confirmed. A confirmed announcement would be dealt with in a separate update, and until then the run stands as a price event only.

What the AVIENCE BIOMEDICALS Upper Circuit Means

A streak of 2 sessions at the limit tells what the band allowed twice, not what comes next. The exchange sets the upper circuit as the highest permitted price for the session, which for AVIENCE BIOMEDICALS LTD was Rs 270.9 on 28 October 2026.

The band exists to temper abrupt swings and keep trading orderly, and it is a rule of market structure rather than a return forecast, so the second session at Rs 270.9 is a fact about the past and nothing more.

AVIENCE BIOMEDICALS LTD Fundamentals and Valuation

Market data supplies more than the price does. AVIENCE BIOMEDICALS LTD has EPS of 15.96, book value of Rs 44.18, a PE ratio of 16.17 and a PB ratio of 5.84, on a market cap of Rs 141.51 crore, and it operates in Healthcare, under Medical Equipment/Supplies/Accessories. None of this is a buy, sell or hold view.

A PB ratio of 5.84 against book value of Rs 44.18 per share means the market is paying several times the accounting value of the shares. Reasons could include growth expectations, asset quality or thin trading in a smaller counter, and the ratio alone does not decide between them.

After two sessions at the limit, the valuation and the return profile deserve their own look, apart from the price run, because a gain of 5% in a session says little about earnings quality or the strength of the balance sheet.

Peer and Sector Context

AVIENCE BIOMEDICALS LTD belongs to the Medical Equipment/Supplies/Accessories industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Q-LINE BIOTECH LIMITED	Rs 1280.83 crore	22.99	5.06	25.55%
3B Blackbio Dx Ltd.	Rs 1191.23 crore	21.45	3.57	20.22%
LAXMI DENTAL LIMITED	Rs 994.11 crore	32.18	4.05	11.95%
Hemant Surgical Industries Ltd.	Rs 823.99 crore	45.3	5.73	12.73%
Osel Devices Ltd.	Rs 598.61 crore	20.49	2.99	18.97%

Several of these peers are far larger by market capitalisation than AVIENCE BIOMEDICALS LTD. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

AVIENCE BIOMEDICALS LTD's PE ratio was 16.17, compared with an available peer PE average of 28.48, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

Technical indicators were limited in the latest market dataset, so this article does not draw a technical conclusion beyond the confirmed upper circuit event.

What Readers Should Know

The firm facts: AVIENCE BIOMEDICALS LTD held the NSE upper circuit of Rs 270.9 on 28 October 2026 for a second session, up 5% on the day.

With the price at its limit, an order placed on the buy side may sit unfilled while holders wait. No official catalyst was confirmed when this was written.

This is a market update and not an investment conclusion. The business, its financial strength, liquidity, risk and its filings are all points to examine apart from the price, since a quote pinned at a band cannot speak for any of them.

Frequently Asked Questions

Why did AVIENCE BIOMEDICALS LTD hit upper circuit on 28 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

How many sessions has AVIENCE BIOMEDICALS LTD hit upper circuit in a row?

This is session 2 of the current run, which began on 27 October 2026. This page is updated each session rather than replaced with a new article.

What was AVIENCE share price on 28 October 2026?

The last traded price used in this article was Rs 270.9 on NSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for AVIENCE?

The upper circuit price was Rs 270.9. The stated exchange upper circuit limit was Rs 270.9. The event numbers in this article are aligned to NSE.

What is AVIENCE BIOMEDICALS LTD's market cap and PE ratio?

AVIENCE BIOMEDICALS LTD's market cap was Rs 141.51 crore. PE ratio was 16.17.

Which exchange and data source were used?

The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting an upper circuit mean AVIENCE BIOMEDICALS LTD is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell AVIENCE BIOMEDICALS LTD shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For AVIENCE BIOMEDICALS LTD the stated limit was Rs 270.9. For this session, AVIENCE BIOMEDICALS LTD moved 5%.